(S)-2-(tert-Butoxycarbonylamino)-4-phenylbutanoic acid

Intermediate for Carfilzomib. Carfilzomib (trade name: Kyprolis) is an anti-cancer drug acting as a selective proteasome inhibitor. Carfilzomib has been approved by the U.S Food and Drug Administration on July 20, 2012.


Product Name:                  (S)-2-(tert-Butoxycarbonylamino)-4-phenylbutanoic acid

Synonyms:                         N/A

CAS Number:                     100564-78-1

Molecular Weight:            279.3352

Molecular Formula:          C15H21NO4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               OC(=O)[C@@H](NC(=O)OC(C)(C)C)CCc1ccccc1

(S)-2-(tert-Butoxycarbonylamino)-4-phenylbutanoic acid

  • $69.00
  • Ex Tax: $69.00

Available Options